Maraka, Stefania <br/><br/>
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.  [electronic resource] 

 -  Cancer  04 2019 
 - 1385-1386 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1097-0142 
<br/><br/><label>Standard No.: </label>10.1002/cncr.31960  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Glioblastoma<br/>Humans<br/>Mefloquine<br/>Memantine<br/>Metformin<br/>Temozolomide